JP2011522874A5 - - Google Patents

Download PDF

Info

Publication number
JP2011522874A5
JP2011522874A5 JP2011513069A JP2011513069A JP2011522874A5 JP 2011522874 A5 JP2011522874 A5 JP 2011522874A5 JP 2011513069 A JP2011513069 A JP 2011513069A JP 2011513069 A JP2011513069 A JP 2011513069A JP 2011522874 A5 JP2011522874 A5 JP 2011522874A5
Authority
JP
Japan
Prior art keywords
influenza
virus
virus strain
vaccine
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011513069A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011522874A (ja
Filing date
Publication date
Priority claimed from GBGB0905570.8A external-priority patent/GB0905570D0/en
Application filed filed Critical
Publication of JP2011522874A publication Critical patent/JP2011522874A/ja
Publication of JP2011522874A5 publication Critical patent/JP2011522874A5/ja
Pending legal-status Critical Current

Links

JP2011513069A 2008-06-12 2009-06-12 季節性および汎流行性の防御のための混合インフルエンザワクチン Pending JP2011522874A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US13191808P 2008-06-12 2008-06-12
US61/131,918 2008-06-12
GBGB0905570.8A GB0905570D0 (en) 2009-03-31 2009-03-31 Combined vaccines
GB0905570.8 2009-03-31
PCT/IB2009/006038 WO2009150532A1 (en) 2008-06-12 2009-06-12 Combined influenza vaccines for seasonal and pandemic protection

Publications (2)

Publication Number Publication Date
JP2011522874A JP2011522874A (ja) 2011-08-04
JP2011522874A5 true JP2011522874A5 (enExample) 2012-07-19

Family

ID=40672059

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011513069A Pending JP2011522874A (ja) 2008-06-12 2009-06-12 季節性および汎流行性の防御のための混合インフルエンザワクチン

Country Status (9)

Country Link
US (2) US20110200635A1 (enExample)
EP (1) EP2303321A1 (enExample)
JP (1) JP2011522874A (enExample)
KR (1) KR20110019417A (enExample)
CN (1) CN102245203A (enExample)
AU (1) AU2009259006A1 (enExample)
CA (1) CA2727322A1 (enExample)
GB (1) GB0905570D0 (enExample)
WO (1) WO2009150532A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE030520T2 (en) * 2008-11-28 2017-05-29 Statens Seruminstitut Optimized influenza vaccines
ES2552383T3 (es) 2009-02-10 2015-11-27 Novartis Ag Regímenes de vacuna de la gripe para cepas asociadas a pandemias
AU2015203072B2 (en) * 2009-02-10 2017-05-25 Seqirus UK Limited Influenza vaccine regimens for pandemic-associated strains
JP2012521786A (ja) 2009-03-30 2012-09-20 モウント シナイ スクール オフ メディシネ インフルエンザウイルスワクチン及びその使用
FR2949344A1 (fr) * 2009-04-27 2011-03-04 Novartis Ag Vaccins de protection contre la grippe
WO2010138564A1 (en) 2009-05-26 2010-12-02 Mount Sinai School Of Medicine Of New York University Monoclonal antibodies against influenza virus generated by cyclical administration and uses thereof
US20120219584A1 (en) * 2009-10-05 2012-08-30 The United States Of America As Represented By The Secretary, Department Of Health Protection against pandemic and seasonal strains of influenza
US9701723B2 (en) 2010-02-18 2017-07-11 Icahn School Of Medicine At Mount Sinai Vaccines for use in the prophylaxis and treatment of influenza virus disease
MX2012011300A (es) 2010-03-30 2012-11-29 Sinai School Medicine Vacunas del virus de influenza y usos de las mismas.
JP5884100B2 (ja) * 2011-08-31 2016-03-15 公益財団法人東京都医学総合研究所 新型インフルエンザウイルス由来ヘマグルチニンタンパク質遺伝子を有するＤＩｓ株由来組換えワクシニアウイルス
HK1200102A1 (en) 2011-09-20 2015-07-31 西奈山医学院 Influenza virus vaccines and uses thereof
JP5918870B2 (ja) * 2012-03-06 2016-05-18 クルセル ホランド ベー ヴェー インフルエンザに対する改善されたワクチン接種
HK1215546A1 (zh) 2012-12-17 2016-09-02 Eurocine Vaccines Ab 鼻内接种疫苗给药方案
NZ627796A (en) 2012-12-18 2017-07-28 Icahn School Med Mount Sinai Influenza virus vaccines and uses thereof
US9908930B2 (en) 2013-03-14 2018-03-06 Icahn School Of Medicine At Mount Sinai Antibodies against influenza virus hemagglutinin and uses thereof
WO2015059284A1 (en) * 2013-10-25 2015-04-30 Leukocare Ag A novel method for the production of stabile vaccines
EP3233117A4 (en) * 2014-12-19 2018-05-16 Oregon Health & Science University Synergistic co-administration of computationally optimized broadly reactive antigens for human and avian h5n1 influenza
WO2016104584A1 (ja) * 2014-12-25 2016-06-30 第一三共株式会社 皮内投与インフルエンザワクチン組成物
EP3247389A4 (en) 2015-01-23 2019-10-30 Icahn School of Medicine at Mount Sinai INFLUENZAVIRUSSCHUTZIMPFPLÄNE
KR20180035807A (ko) 2015-06-26 2018-04-06 세퀴러스 유케이 리미티드 항원적으로 매치된 인플루엔자 백신
MX2018015755A (es) 2016-06-15 2019-08-29 Icahn School Med Mount Sinai Proteinas de hemaglutinina de virus de influenza y usos de las mismas.
CN107151659B (zh) * 2017-03-01 2021-04-02 苏州系统医学研究所 一种流感病毒株及其应用
CA3058652A1 (en) 2017-04-07 2018-10-11 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof
JP7432506B2 (ja) 2017-10-30 2024-02-16 武田薬品工業株式会社 脂質エンベロープウイルスを不活化するための環境適合性の界面活性剤
WO2019143955A1 (en) * 2018-01-22 2019-07-25 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Broadly protective inactivated influenza virus vaccine
US12364746B2 (en) 2018-06-21 2025-07-22 Icahn School Of Medicine At Mount Sinai Mosaic influenza virus hemagglutinin polypeptides and uses thereof
CA3137160A1 (en) 2019-04-24 2020-10-29 Icahn School Of Medicine At Mount Sinai Anti-influenza b virus neuraminidase antibodies and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1645283A1 (en) * 2004-10-08 2006-04-12 Chiron Behring GmbH & Co. KG Combination vaccine
PE20061428A1 (es) * 2005-03-23 2007-01-16 Glaxosmithkline Biolog Sa Formulacion de vacuna que comprende un adyuvante de emulsion aceite en agua y 3d-mpl
WO2007052155A2 (en) * 2005-11-04 2007-05-10 Novartis Vaccines And Diagnostics Srl Influenza vaccine with reduced amount of oil-in-water emulsion as adjuvant
KR101211386B1 (ko) * 2005-11-04 2012-12-13 노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. 알루미늄 보조제에 즉석 흡착되는 인플루엔자 백신
ES2401484T3 (es) * 2006-06-15 2013-04-22 Novartis Ag Régimen de vacunación contra la gripe multidosis ahorrador de adyuvantes
EP3456348B1 (en) * 2006-09-11 2025-03-26 Seqirus UK Limited Making influenza virus vaccines without using eggs
PL2121011T3 (pl) * 2006-12-06 2014-10-31 Novartis Ag Szczepionki zawierające antygeny czterech szczepów wirusa grypy
JP5305427B2 (ja) * 2007-01-11 2013-10-02 公立大学法人大阪府立大学 インフルエンザウイルスに対する抗体の産生方法
WO2008091657A1 (en) * 2007-01-23 2008-07-31 Academia Sinica Flu vaccines and methods of use thereof
GB0810305D0 (en) * 2008-06-05 2008-07-09 Novartis Ag Influenza vaccination
JP2011506290A (ja) * 2007-12-06 2011-03-03 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム インフルエンザ組成物
EP2268309B1 (en) * 2008-03-18 2015-01-21 Novartis AG Improvements in preparation of influenza virus vaccine antigens

Similar Documents

Publication Publication Date Title
Becker et al. Influenza vaccines: successes and continuing challenges
Vasou et al. Targeting pattern recognition receptors (PRR) for vaccine adjuvantation: from synthetic PRR agonists to the potential of defective interfering particles of viruses
Cappellano et al. Nano-microparticle platforms in developing next-generation vaccines
Kumar et al. Novel platforms for the development of a universal influenza vaccine
Cargnin Faccin et al. Pandemic preparedness through vaccine development for avian influenza viruses
Vemula et al. Vaccine approaches conferring cross-protection against influenza viruses
Sekiya et al. Selecting and using the appropriate influenza vaccine for each individual
Zhang et al. Universal influenza vaccines, a dream to be realized soon
Isakova-Sivak et al. Influenza vaccine: Progress in a vaccine that elicits a broad immune response
Li et al. Adjuvantation of influenza vaccines to induce cross-protective immunity
JP6185548B2 (ja) インフルエンザワクチンの製造方法
Clegg et al. Clinical vaccine development for H5N1 influenza
Trucchi et al. Universal influenza virus vaccines: what needs to happen next?
ES2469568T3 (es) Vacuna contra la gripe
Quan et al. Progress in the development of virus-like particle vaccines against respiratory viruses
CN102548577A (zh) 用于抵抗流感的佐剂疫苗
Hatz et al. A randomized clinical trial to identify the optimal antigen and MF59® adjuvant dose of a monovalent A/H1N1 pandemic influenza vaccine in healthy adult and elderly subjects
Rudenko et al. Pandemic preparedness with live attenuated influenza vaccines based on A/Leningrad/134/17/57 master donor virus
Hsiung et al. Vaccine strategies against RNA viruses: current advances and future directions
Chu et al. Respiratory viruses and virus-like particle vaccine development: how far have we advanced?
Mokalla et al. Influenza vaccines: current status, adjuvant strategies, and efficacy
Esposito et al. Preventing influenza in younger children
Tosh et al. Emerging vaccines for influenza
Deans et al. Influenza vaccines provide diminished protection but are cost‐saving in older adults
EP2822585B1 (en) Improved vaccination against influenza